Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 1.02T | 967.69B | 939.90B | 939.43B | 917.47B | 1.01T |
Gross Profit | 346.99B | 332.35B | 314.45B | 302.44B | 287.91B | 321.68B |
EBITDA | 341.11B | 327.79B | 305.91B | 294.53B | 277.06B | 288.13B |
Net Income | 178.28B | 177.17B | 161.93B | 150.45B | 141.39B | 141.00B |
Balance Sheet | ||||||
Total Assets | 6.66T | 6.68T | 6.37T | 5.81T | 5.67T | 5.32T |
Cash, Cash Equivalents and Short-Term Investments | 70.47B | 103.91B | 185.12B | 151.39B | 188.34B | 195.36B |
Total Debt | 3.90T | 3.96T | 3.94T | 3.56T | 3.56T | 3.44T |
Total Liabilities | 4.50T | 4.63T | 4.57T | 4.17T | 4.17T | 4.02T |
Stockholders Equity | 2.16T | 2.05T | 1.80T | 1.63T | 1.50T | 1.29T |
Cash Flow | ||||||
Free Cash Flow | 0.00 | 43.64B | -284.23B | 13.41B | -129.48B | -39.89B |
Operating Cash Flow | 0.00 | 232.03B | 165.11B | 192.97B | 225.95B | 230.46B |
Investing Cash Flow | 0.00 | -310.69B | -489.80B | -209.98B | -336.68B | -290.12B |
Financing Cash Flow | 0.00 | -3.65B | 355.56B | -21.92B | 102.09B | 82.64B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
74 Outperform | $2.68T | 13.97 | 8.93% | 1.24% | 4.81% | 8.36% | |
53 Neutral | $1.20B | 3.25 | -0.13% | 7.08% | -1.64% | -127.49% | |
$7.69B | 12.26 | 12.74% | 0.02% | ― | ― | ||
€1.17B | 10.60 | 24.21% | 1.60% | ― | ― | ||
$5.33B | 10.17 | 10.23% | 0.03% | ― | ― | ||
$3.67B | 8.26 | 12.90% | 5.92% | ― | ― | ||
81 Outperform | ¥187.55B | 11.89 | 2.37% | 8.04% | 167.85% |